Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression
- 15 January 2002
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (2), 351-358
- https://doi.org/10.1016/s0735-1097(01)01729-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Endothelial Dysfunction in Human DiseaseJournal of Molecular and Cellular Cardiology, 1999
- NO: the Primary EDRFJournal of Molecular and Cellular Cardiology, 1999
- Angiotensin-Converting Enzyme Inhibition Alters Nitric Oxide and Superoxide Release in Normotensive and Hypertensive RatsHypertension, 1997
- Endothelial Dysfunction Coincides With an Enhanced Nitric Oxide Synthase Expression and Superoxide Anion ProductionHypertension, 1997
- Aorta and Skeletal Muscle NO Synthase Expression in Experimental Heart FailureJournal of Molecular and Cellular Cardiology, 1996
- p22 Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1996
- Effect of Chronic Angiotensin-Converting Enzyme Inhibition on Endothelial Function in Patients with Chronic Heart FailureThe American Journal of Cardiology, 1995
- Endothelial function in chronic congestive heart failureThe American Journal of Cardiology, 1992
- Oxygen free radicals and congestive heart failure.Heart, 1991